Ulcers
now browsing by category
Black cumin plus vitamin D equals a top antiviral combination
Reproduced from original OMNS article (OrthoMolecular News Service):
http://orthomolecular.org/
Subscribe to the free Orthomolecular Newsletter: http://orthomolecular.org/subscribe.html
Go to the OMNS Archive: http://orthomolecular.org/resources/omns/index.shtml
Orthomolecular Medicine News Service, June 1, 2023
The remarkable clinical versitility of Nigella sativa
by Max Langen
OMNS (June 1, 2023) Nigella sativa, also called black cumin, is one of the most important medicinal plants. Its seeds (sometimes called “black seeds”) have been used for thousands of years as a spice and condiment, and in several traditional medicine systems to treat a wide range of diseases. This plant is described and acknowledged in ancient medical and religious literature. The Bible mentions Nigella sativa as “Curative black seed,” and it is also known as prophetic medicine, since Prophet Muhammad, the founder of Islam, referred to it as “cure for every disease except death.” It was mentioned in Chinese and Indian traditional medicine and was also described in traditional Arab and Islamic medicine. [1-3]
The biochemical content of nigella sativa seeds includes oils (30-40%), essential oils including thymoquinone, nigellidine, and PUFAs, and many other proteins (~25%), minerals, fatty acids, alkaloids, sterols (alpha-hederine), phenolics, flavonoids, and saponins. Recent clinical studies have shown that seeds of nigella sativa and their major compounds including thymoquinone have strong immunomodulatory, anti-inflammatory, anti-oxidant, antiviral, antibacterial, antimalarial, antifungal, antihistaminic, anticancer, antidiabetic, anti-epileptic, anti-asthmatic, anti-allergic, antitussive, anticoagulant, analgesic, cardioprotective, hepatoprotective, gastroprotective and neuroprotective effects, among others. [1-3]
Nigella sativa has shown in several studies to be highly effective for the prevention and treatment of Covid-19, massively reducing severe outcomes and mortality. Many could still be alive had this therapy not been widely ignored. Also, the combination of nigella sativa and vitamin D has shown to be remarkably effective in the clearance of a viral infection.
Before looking more closely at those impressive results from studies on Covid-19, here are short summaries of what recent clinical studies have shown about the healing effects of nigella sativa for other conditions, including other infectious diseases. As of April 2023, there are more than 1900 scientific publications on nigella sativa. More than 90 randomized controlled trials (RCTs) and meta-analyses of RCTs have been published to date that tested the effectiveness of nigella sativa for various diseases and health outcomes, with a large majority of them showing clear benefits. This evidence suggests that nigella sativa could be used as an effective (adjuvant) treatment to improve many conditions. RCTs, often placebo-controlled, or meta-analyses of RCTs have shown that nigella sativa, often administered as capsules with 1000 or 2000 mg of nigella sativa seed oil, or pharmaceutical powder of the seeds (and sometimes given in other forms, for example as pure, non-powdered nigella sativa seeds or as topical ointment/gel application) can effectively:
- reduce hypertension by lowering both systolic and diastolic blood pressure. [4]
- support achieving and maintaining a healthy weight in overweight individuals by helping to moderately reduce weight and body mass index. [5]
- treat metabolic syndrome, by reducing body mass index, waist circumference and body fat percentage, fasting glucose and lipid levels. The combination of nigella sativa + turmeric was even more effective. [6]
- improve glucose status in patients with type 2 diabetes, by decreasing fasting plasma glucose, postprandial glucose and long term glucose (HbA1c) levels. [7] In patients with prediabetes, it reduces glycemic and anthropometric parameters just as effectively as the drug metformin. [8]
- decrease blood lipid levels, including total cholesterol, very low density cholesterol, LDL cholesterol and triglycerides for individuals with excessive levels. [9]
- treat nonalcoholic fatty liver disease by improving the grades of liver steatosis, injury and fatty liver. Various liver and cholesterol parameters improved. [10,11]
- increase total antioxidant capacity and reduce oxidative stress. [12]
- reduce inflammatory processes (especially hs-CRP and TNF-alpha), suggesting that it decreases chronic inflammation. [12] Of note, chronic low-grade inflammatory processes are important causes of most diseases and conditions including cancer.
- improve cardiovascular health and therefore reduce the risk of cardiovascular diseases via many different mechanisms (incl. reduction of hypertension, cholesterol and body weight, glucose regulation, reduction of silent inflammation and oxidative stress etc.) In patients at increased risk of cardiovascular disease, it also improved flow-mediated dilation, the level of nitric oxide, and lowered mean arterial pressure and heart rate, [13,14] suggesting that it can greatly stabilize the health of the cardiovascular system.
- improve kidney parameters, suggesting that it may help maintain or increase health of the kidneys. [9] In patients with (advanced) chronic kidney disease (stage 3 or 4) due to diabetic nephropathy, it reduced blood glucose and improved kidney parameters incl. serum creatinine and glomerular filtration rate etc. suggesting that it may stop the progression of kidney disease or even help reverse it. [15] An additional study confirmed that patients with advanced kidney disease greatly improve by nigella sativa. The addition of nigella sativa to the treatment protocol caused a “marked improvement” in clinical features and kidney parameters. [16]
- dissolve kidney stones. In the nigella sativa group, 44% of patients excreted their kidney stones completely, and in a further 52% the size of the stones was reduced. In the placebo group, only 15% excreted their stones, 12% had a reduction of stone size, and 15% even had an increase of stone size. [17] This suggests nigella sativa may also prevent kidney stone formation.
- improve Hashimoto thyroiditis, which is one of the most common autoimmune diseases. TSH, antibodies against the thyroid and vascular endothelial growth factor decreased, while the thyroid hormone T3 level increased, suggesting that it helps reverse the disease, strengthens the health of the thyroid and may also be an effective treatment for autoimmune diseases in general. [18] As will be shown below, nigella sativa has already shown to be effective for several autoimmune conditions: rheumatoid arthritis, ulcerative colitis, psoriasis, vitiligo and asthma.
- decrease the severity of rheumatoid arthritis. Swollen joints and morning stiffness were also reduced. [19]
- reduce stool frequency in patients with ulcerative colitis. [20]
- improve psoriasis. Both oral and gel administration of nigella sativa were effective in most patients and led to improvements after several weeks of treatment. However, the combination of both oral and gel administration led to the best outcomes. 55% of psoriasis patients who received this combination achieved a good response. Further, 30% even had an excellent response or achieved a complete cure. Of note, if the treatment was stopped, the condition returned in some patients, indicating that it may be helpful for these patients to continue the treatment. [21]
- treat vitiligo (patchy skin pigmentation). Nigella sativa (as a gel application) was more effective than fish oil in reducing the vitiligo area scoring index. [22]
- treat hand eczema. Nigella sativa (as gel application) was just as effective as the drug betamethasone, reducing the severity of hand eczema and increasing quality of life in the affected patients. [23]
- treat dermatitis. Nigella sativa reduced the symptoms and signs of occupational contact dermatitis like eczematous lesions. In many patients, dermatitis improved or disappeared completely. Of note, oral capsules were more effective than topical administration. [24]
- treat acne vulgaris (as gel application). After 2 months, the acne disability index had declined by 64% in the Nigella sativa group, compared with 5% in the placebo group. [25]
- reduce symptoms of asthma (shortness of breath, night time waking, interference with activity), reduce rescue treatment and inhaler use, rating of asthma control, and improve lung function measured as forced expiratory volume at 1 second (FEV1). [26]
- treat impaired lung function in chemical war victims. Nigella sativa (as boiled extract) improved pulmonary function, chest wheezing and all other respiratory symptoms. The need to use inhalers and drugs decreased, suggesting that it may at least partially substitute for drugs. [27]
- treat allergic conditions, including allergic rhinitis, by reducing runny nose, nasal congestion, sneezing attacks, nasal itching, turbinate hypertrophy etc. in affected patients. [28,29]
- reduce knee osteoarthritis symptoms and pain. [30] Nigella sativa (as gel/oil application) was more effective in relieving pain (51% reduction) than the common pharmaceutical pain reliever diclofenac (14% reduction). [31]
- improve symptoms of menopausal women (in combination with another herbal medication: Vitex agnus-castus). Psychosocial, physical and vasomotor (hot flashes) symptoms decreased. [33]
- treat polycystic ovary syndrome. It was effective in the treatment of menstrual irregularities in women with PCOS. [34]
- stabilize/increase mood, calmness and cognition, and decrease anxiety. [35]
- treat major depressive disorder. In the intervention group that received the antidepressant sertraline + Nigella sativa capsules, the depression scores declined more than in the control group that only received sertraline + placebo. [36]
- increase attention and memory, suggesting that it may help prevent cognitive decline and dementia. [37]
- treat epilepsy in patients resistant to conventional anti-epileptic drugs. Administration of the aqueous extract of Nigella sativa or high dose thymoquinone (one of its main active ingredients) reduced the frequency of epileptic seizures. [38,39]
- improve nasal dryness, obstruction and crusting (as intranasal application) in older people suffering from nasal mucosa symptoms. [40]
- improve oral submucous fibrosis. Burning sensation decreased by 80% after continuous application of nigella sativa. Mouth opening was also reduced. [41]
- treat alveolar osteitis/dry socket (painful inflammation following tooth extraction). Nigella sativa (as oil and powder) was a more effective dressing material than a commonly used commercial dressing. Those who received this treatment had immediate and complete pain relief and required less repeated visits. [42]
- improve recovery of oral cavity ulcers or traumatic ulcers. [43]
- treat gingivitis. Nigella sativa oil reduced the gingival index score, inflammation, and pathogenic (streptococcus) bacteria. By decreasing biofilm formation and disrupting the colonization of such bacteria, it may help reduce the progression of periodontal diseases. It was as effective as chlorhexidine, suggesting that nigella sativa could be an alternative to chemical mouthwashes. [44]
- treat insomnia. Nigella sativa restored restful sleep in patients with sleep issues. [45]
- improve irritable bowel syndrome after some weeks of continuous intake. Severity of the disease symptoms, abdominal distention and the impact of the condition on daily life decreased, and defecation improved. [46]
- reduce urinary incontinence (in older women). [47]
- improve semen quality (sperm count, motility, morphology, volume etc.) in infertile men, suggesting that it may help reverse infertility and increase pregnancy rates. [48]
- treat female infertility by improving reproductive parameters including the number of ovarian follicles and reducing oxidative stress and may therefore help reverse female infertility and increase pregnancy rates. [49]
- increase volume of breastmilk in breastfeeding mothers. [50]
- treat (chronic) rhinosinusitis. Nigella sativa (as nasal drops) reduced the congestion, pain, numbness, pressure, fullness and bad breath in patients with chronic rhinosinusitis. [51]
- treat arsenic poisoning in patients with palmar arsenical keratosis. Nigella sativa reduced the body arsenic load, which led to an improvement of arsenical keratosis. Therefore, it might also support detoxification of other toxic metals. [52]
- improve immune health. Nigella sativa (1 g of seed oil per day) has an immunopotentiating effect, increasing total lymphocyte count, CD3+ and CD4+ cells, suggesting that it reduces the risk of infectious diseases. [53]
- prevent side effects of toxic cancer therapies: Nigella sativa (as a gel application) reduced the incidence and severity of phlebitis (inflammation of veins), a common complication of intravenous chemotherapy. [54] As a mouth rinse it decreased the severity of chemotherapy-induced oral mucositis. Erythema, ulceration and pain were reduced. Therefore, it enabled those patients to consume normal food. [55] Nigella sativa (as a gel application) reduced the risk of developing acute radiation dermatitis in breast cancer patients treated with radiotherapy. [56] Nigella sativa also reduced the risk of developing febrile neutropenia (FN), a dangerous complication of chemotherapy. Chemotherapy harms the immune system and often leads to a reduction of immune cells (neutrophil granulocytes). 5 grams of nigella sativa seeds per day greatly reduced the risk of developing a chemotherapy-induced FN, inhibiting the harm done to the immune system and reducing by almost 90% severe or deadly (viral, bacterial, fungal) infections. [57]
- treat hepatitis C infections by attenuating viral load. 50% of hepatitis C patients treated with (a relatively low dose of) nigella sativa had a decrease in the quantitative viral load and 17% even became seronegative. [58] A higher dose might have been even more effective. Of note, another study also showed that hepatitis can be treated more effectively by adding nigella sativa and vitamin C to conventional therapy. [59]
- treat vaginitis caused by a candida albicans infection. Standard therapy + nigella sativa was more effective in reducing several symptoms and signs of candida-induced vaginitis compared with standard therapy + placebo. [60]
- eradicate helicobacter pylori infections (bacteria), which are among the leading causes of gastric cancer. Resistance of helicobacter towards pharmaceutical drugs has recently increased alarmingly. Eradication of helicobacter occurred in almost 60% of patients who were treated with high dose nigella sativa + honey. [61] Double-blind RCTs confirmed that patients who received standard therapy + nigella sativa achieved a greater eradication. [62,63]
- treat staphylococcal skin infections. In neonates with staphylococcal skin infections, it was similarly effective as the antibacterial drug mupirocin. [64]
- inhibit bacterial wound infections caused by staphylococcus aureus. A lab study with samples obtained from cases of wound infections in a hospital showed that high dose thymoquinone may inhibit s. aureus and therefore prevent/treat such wound infections. [65]
- inhibit MRSA (methicillin resistant staphylococcus aureus), which is one of the deadliest bacterial infections often acquired in a hospital. Nigella sativa (in high concentrations in a preclinical study) was shown to have inhibitory effects against MRSA. [66] It also had inhibitory effects against vancomycin resistant staphylococcus aureus (VRSA). [67]
- accelerate the recovery of acute respiratory infections overall (flu/cold etc.). Patients with an acute respiratory infection who received nigella sativa had a greater chance of becoming symptom-free after only 4 days. [68] A combination of nigella sativa oil + echinacea extract + garlic powder + panax ginseng extract + vitamin C + zinc cut the duration of a common cold in half (4 vs. 8 days of median recovery time). [69]
Treating Covid-19
Nigella sativa not only prevented Covid-19 in many people, but also accelerated the recovery and greatly reduced the development of severe symptoms or death in patients with Covid-19. [3] Several compounds of nigella sativa, including thymoquinone, nigellidine and alpha-hederin have proven antiviral and anti-inflammatory effects. Thymoquinone can inhibit the main protease in SARS-CoV-2, causing a “strong anti-SARS-CoV-2 activity.” [70]
A prospective prophylaxis study with 376 participants has shown that daily consumption of 40 mg/kg of nigella sativa seeds (= 3000 mg per day for a 75 kg person) reduced the risk of developing a symptomatic case of Covid-19 by more than 60%. Of note, the results of this study were available in Jan 2021. [71] A widespread recommendation to use nigella sativa would therefore have been an effective way to limit the pandemic and reduce the incidence of symptomatic infections in the population.
In a recent RCT with hospitalized Covid-19 patients, the treated group received standard therapy and 80 mg/kg/day of encapsulated nigella sativa seeds plus 1 g/kg/day of honey. [72] The results showed that the treated group had significantly faster viral clearance and recovery. In fact, those who received NS + honey recovered almost twice as fast. Overall, the patients in the treated group had a 82% lower risk of death compared with the control group. Importantly, these striking results of this high quality study were available in Nov. 2020, during the first year of the pandemic. [73]
Therefore, by 2020 it was clear that this treatment could reduce the fatality rate of hospitalized Covid-19 patients by 80%. Since then, millions of Covid-19 patients have died, but many of these deaths could have been easily prevented, not only with nigella sativa and honey, but also with other natural and orthomolecular treatment protocols that have shown to be similarly effective in reducing mortality of Covid-patients. [74,75]
Importantly, earlier treatment with nigella sativa can even prevent the progression and development of severe stages of Covid-19. A recent RCT showed that, if treatment with nigella sativa is started early in the disease course, shortly after symptoms begin, serious complications (and therefore hospitalization etc.) can be strongly reduced. Among those patients who only received the standard treatment, 17% developed a severe case. However, among those who received nigella sativa seeds for a duration of 2 weeks, only 1% developed severe symptoms, a 93% reduction. The results of this RCT were published in Jan 2021. [76]
A recent RCT confirmed that daily treatment with 1000 mg of nigella sativa seed oil (in capsules) improves recovery from Covid-19. The patients in the intervention group (standard therapy + nigella sativa) recovered significantly faster from Covid-symptoms than those in the control group (who only received standard therapy). The intervention group had a 75% lower risk of requiring hospitalization. [77]
In another RCT, Covid-19 outpatients were divided into four groups:
Group 1 received standard therapy + nigella sativa capsules, group 2 received standard therapy + vitamin D, group 3 received standard therapy + a combination of both nigella sativa and vitamin D and group 4 received only standard therapy (control group). The results showed that while viral clearance and symptom recovery occurred faster in groups 1 and 2 compared with the control group, the combination group that received both nigella sativa + vitamin D had the most impressive results with regard to recovery of the disease. The authors noted the remarkably fast viral clearance and reduction of many symptoms in this combination group and recommended this treatment for Covid-patients. [78] It is therefore highly likely that nigella sativa + vitamin D may also be a very effective treatment combination for other (infectious) diseases. They may have synergistic effects.
The evidence clearly shows: Had nigella sativa been used widely to treat Covid-19, many lives could have been saved. Unfortunately, however, governments around the world chose to recommend (or enforce) an experimental prophylactic drug, which caused massive numbers of serious adverse events and injuries [79] and led to significant excess mortality. [80] Analyses from various countries clearly showed that the higher the uptake of this experimental drug in 2021, the stronger the increase in excess deaths in 2022. Extensive mortality analyses by many scientists indicate that these drugs caused the deaths of 6.5 to 13 million people worldwide. [81]
Even before the roll-out of those experimental drugs, many people died from side effects of typical conventional medicine. Prescription drugs are one of the leading causes of death in Europe and in the United States of America. [82] Orthomolecular or natural medicine has been shown to be highly effective for many conditions and diseases, suggesting that most of these deaths from conventional drugs could easily be prevented by more widespread use of natural treatment approaches. Of course, each individual’s situation is different and may require different treatment approaches. Health issues should always be discussed with an orthomolecular or natural health care provider who can offer medical advice and help finding the best natural (or natural + conventional) treatment for an individual.
Many nigella sativa products are available and not all of them are high quality. When choosing nigella sativa capsules (rather than consuming the raw seeds in sufficient amounts), one should make sure that the seed oil is cold-pressed, to ensure that the capsules contain the seeds’ effective compounds. The color of the oil needs to be golden and a bitter smell/taste should prevail. A lighter yellow color would be a negative sign, which indicates that too many of the compounds have been removed during the processing.
References:
1. Ahmad MF, Ahmad FA, Ashraf SA, et al. (2021) An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J Herb Med. 25:100404. https://pubmed.ncbi.nlm.nih.gov/32983848
2. Ijaz H, Tulain UR, Qureshi J, et al. (2017) Review: Nigella sativa (Prophetic Medicine): A Review. Pak J Pharm Sci. 30:229-234. https://pubmed.ncbi.nlm.nih.gov/28603137
3. Maideen NMP (2020) Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19? J Pharmacopuncture. 23:62-70. https://pubmed.ncbi.nlm.nih.gov/32685234
4. Sahebkar A, Soranna D, Liu X, et al. (2016) A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure. J Hypertens. 34:2127-2135. https://pubmed.ncbi.nlm.nih.gov/27512971
5. Mousavi SM, Sheikhi A, Varkaneh HK, et al. (2018) Effect of Nigella sativa supplementation on obesity indices: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 38:48-57. https://pubmed.ncbi.nlm.nih.gov/29857879
6. Amin F, Islam N, Anila N, Gilani AH. (2015) Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome – a double blind randomized controlled trial – TAK-MetS trial. Complement Ther Med. 23:165-174. https://pubmed.ncbi.nlm.nih.gov/25847554
7. Askari G, Rouhani MH, Ghaedi E, et al. (2019) Effect of Nigella sativa (black seed) supplementation on glycemic control: A systematic review and meta-analysis of clinical trials. Phytother Res. 33:1341-1352. https://pubmed.ncbi.nlm.nih.gov/30873688
8. Mostafa TM, Hegazy SK, Elnaidany SS, et al. (2021) Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin. J Diabetes Complications 35:107947. https://pubmed.ncbi.nlm.nih.gov/34006388
9. Razmpoosh E, Safi S, Abdollahi N, et al. (2020) The effect of Nigella sativa on the measures of liver and kidney parameters: A systematic review and meta-analysis of randomized-controlled trials. Pharmacol Res. 156:104767. https://pubmed.ncbi.nlm.nih.gov/32201245
10. Tang G, Zhang L, Tao J, Wei Z. (2021) Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 35:4183-4193. https://pubmed.ncbi.nlm.nih.gov/33728708
11. Khonche A, Huseini HF, Gholamian M, et al. (2019) Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial. J Ethnopharmacol. 234:106-111. https://pubmed.ncbi.nlm.nih.gov/30639231
12. Montazeri RS, Fatahi S, Sohouli MH, et al. (2021) The effect of nigella sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Food Biochem. 45:e13625. https://pubmed.ncbi.nlm.nih.gov/33559935
13. Emamat H, Mousavi SH, Kargar Shouraki J, et al. (2022) The effect of Nigella sativa oil on vascular dysfunction assessed by flow-mediated dilation and vascular-related biomarkers in subject with cardiovascular disease risk factors: A randomized controlled trial. Phytother Res. 36:2236-2245. https://pubmed.ncbi.nlm.nih.gov/35412685
14. Badar A, Kaatabi H, Bamosa A, (2017) Al-Elq A, Abou-Hozaifa B, Lebda F, Alkhadra A, Al-Almaie S. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Ann Saudi Med. 37:56-63. https://pubmed.ncbi.nlm.nih.gov/28151458
15. Ansari ZM, Nasiruddin M, Khan RA, Haque SF (2017) Protective role of Nigella sativa in diabetic nephropathy: A randomized clinical trial. Saudi J Kidney Dis Transpl. 28:9-14. https://pubmed.ncbi.nlm.nih.gov/28098097
16. Alam MA, Nasiruddin M, Haque SF, Khan RA. (2020) Evaluation of safety and efficacy profile of Nigella sativa oil as an add-on therapy, in addition to alpha-keto analogue of essential amino acids in patients with chronic kidney disease. Saudi J Kidney Dis Transpl. 31:21-31. https://pubmed.ncbi.nlm.nih.gov/32129194
17. Ardakani Movaghati MR, Yousefi M, Saghebi SA, et al. (2019) Efficacy of black seed (Nigella sativa L.) on kidney stone dissolution: A randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 33:1404-1412. https://pubmed.ncbi.nlm.nih.gov/30873671
18. Farhangi MA, Dehghan P, Tajmiri S, Abbasi MM. (20106) The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) – 1, Nesfatin-1 and anthropometric features in patients with Hashimoto’s thyroiditis: a randomized controlled trial. BMC Complement Altern Med. 16:471. https://pubmed.ncbi.nlm.nih.gov/27852303
19. Gheita TA, Kenawy SA. (2012) Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytother Res. 26:1246-8. https://pubmed.ncbi.nlm.nih.gov/22162258
20. Nikkhah-Bodaghi M, Darabi Z, Agah S, Hekmatdoost A. (2019) The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytother Res. 33:1027-1032. https://pubmed.ncbi.nlm.nih.gov/30666747
21. Ahmed Jawad H, Ibraheem Azhar Y, Al-Hamdi Khalil I (2014) Evaluation of efficacy, safety and antioxidant effect of Nigella sativa in patients with psoriasis: A randomized clinical trial. Journal of Clinical and Experimental Investigations. 5:186-193. https://un.uobasrah.edu.iq/papers/4104.pdf
22. Ghorbanibirgani A, Khalili A, Rokhafrooz D. (2014) Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo. Iran Red Crescent Med J. 16:e4515. https://pubmed.ncbi.nlm.nih.gov/25068060
23. Yousefi M, Barikbin B, Kamalinejad M, et al. (2013) Comparison of therapeutic effect of topical Nigella with Betamethasone and Eucerin in hand eczema. J Eur Acad Dermatol Venereol. 27:1498-1504. https://pubmed.ncbi.nlm.nih.gov/23198836
24. Saad A, Besher S, Ammar N, Emam, H (2001) Therapeutic effects of Nigella Sativa on occupational contact dermatitis. Central European J Occ and Env Med. 7:26-38. https://www.researchgate.net/profile/Amal-Saad-Hussein/publication/230838076_THERAPEUTIC_EFFECTS_OF_NIGELLA_SATIVA_ON_OCCUPATIONAL_CONTACT_DERMATITIS/links/0912f5051cf358aed8000000/THERAPEUTIC-EFFECTS-OF-NIGELLA-SATIVA-ON-OCCUPATIONAL-CONTACT-DERMATITIS.p
25. Soleymani S, Zargaran A, Farzaei MH, et al. (2020) The effect of a hydrogel made by Nigella sativa L. on acne vulgaris: A randomized double-blind clinical trial. Phytother Res. 34:3052-3062. https://pubmed.ncbi.nlm.nih.gov/32548864
26. Han A, Shi D. (2021) The efficacy of Nigella sativa supplementation for asthma control: a meta-analysis of randomized controlled studies. Postepy Dermatol Alergol. 38:561-565. https://pubmed.ncbi.nlm.nih.gov/34658694
27. Boskabady MH, Farhadi J. (2008) The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 14:1137-1144. https://pubmed.ncbi.nlm.nih.gov/18991514
28. Nikakhlagh S, Rahim F, Aryani FH, et al. (2011) Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol. 32:402-407. https://pubmed.ncbi.nlm.nih.gov/20947211
29. Kalus U, Pruss A, Bystron J, et al. (2003) Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res. 17:1209-1214. https://pubmed.ncbi.nlm.nih.gov/14669258
30. Huseini HF, Mohtashami R, Sadeghzadeh E, et al. (2022) Efficacy and safety of oral Nigella sativa oil for symptomatic treatment of knee osteoarthritis: A double-blind, randomized, placebo-controlled clinical trial. Complement Ther Clin Pract. 49:101666. https://pubmed.ncbi.nlm.nih.gov/36150238
31. Azizi F, Ghorat F, Rakhshani MH, Rad M (2019) Comparison of the effect of topical use of Nigella Sativa oil and diclofenac gel on osteoarthritis pain in older people: A randomized, double-blind, clinical trial. J Herb Med. 16:100529. https://www.sciencedirect.com/science/article/abs/pii/S2210803319300053
32. Huseini HF, Kianbakht S, Mirshamsi MH, Zarch AB. (2016) Effectiveness of Topical Nigella sativa Seed Oil in the Treatment of Cyclic Mastalgia: A Randomized, Triple-Blind, Active, and Placebo-Controlled Clinical Trial. Planta Med. 82:285-288. https://pubmed.ncbi.nlm.nih.gov/26584456
33. Molaie M, Darvishi B, Jafari Azar Z, et al. (2019) Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis. Gynecol Endocrinol. 35:58-61. https://pubmed.ncbi.nlm.nih.gov/30129806
34. Naeimi SA, Tansaz M, Hajimehdipoor H, Saber S (2020) Comparing the Effect of Nigella sativa oil Soft Gel and Placebo on Oligomenorrhea, Amenorrhea and Laboratory Characteristics in Patients with Polycystic Ovarian Syndrome, a Randomized Clinical Trial. Res J Pharmacogn. (RJP) 7:49-58. https://www.rjpharmacognosy.ir/article_99289_f5613bb45b6fb6dd8a7a2a9b5f7857a1.pdf
35. Bin Sayeed MS, Shams T, Fahim Hossain S, et al. (2014) Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males. J Ethnopharmacol. 152:156-162. https://pubmed.ncbi.nlm.nih.gov/24412554
36. Zadeh AR, Eghbal AF, Mirghazanfari SM, et al. (2022) Nigella sativa extract in the treatment of depression and serum Brain-Derived Neurotrophic Factor (BDNF) levels. J Res Med Sci. 27:28. https://pubmed.ncbi.nlm.nih.gov/35548175
37. Bin Sayeed MS, Asaduzzaman M, Morshed H, et al. (2013) The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers. J Ethnopharmacol. 148:780-786. https://pubmed.ncbi.nlm.nih.gov/23707331
38. Akhondian J, Parsa A, Rakhshande H. (2007) The effect of Nigella sativa L. (black cumin seed) on intractable pediatric seizures. Med Sci Monit. 13:CR555-9. 4 https://pubmed.ncbi.nlm.nih.gov/18049435
39. Akhondian J, Kianifar H, Raoofziaee M, et al. (2011) The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res. 93:39-43. https://pubmed.ncbi.nlm.nih.gov/21112742
40. Oysu C, Tosun A, Yilmaz HB, et al. (2014) Topical Nigella Sativa for nasal symptoms in elderly. Auris Nasus Larynx. 41:269-272. https://pubmed.ncbi.nlm.nih.gov/24398317
41. Pipalia PR, Annigeri RG, Mehta R. (2016) Clinicobiochemical evaluation of turmeric with black pepper and nigella sativa in management of oral submucous fibrosis-a double-blind, randomized preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 122:705-712. https://pubmed.ncbi.nlm.nih.gov/27720650
42. Khan ZA, Prabhu N, Ahmed N, et al. (2022) A Comparative Study on Alvogyl and a Mixture of Black Seed Oil and Powder for Alveolar Osteitis: A Randomized Double-Blind Controlled Clinical Trial. Int J Clin Pract. 2022:7756226. https://pubmed.ncbi.nlm.nih.gov/35685605
43. Sadat Afraz E, Kazemi S, Ghaneei F, et al. (2022) The Healing Effects of Nigella sativa Gel on Oral Traumatic Ulcer. Int J BioLife Sci. 1:118. https://www.jobiost.com/article_162053.html
44. Rahman I, Mohammed A, AlSheddi MA, et al. (2023) Nigella sativa oil as a treatment for gingivitis: A randomized active-control trial. Asian Pac J Trop Med. 16:129-1138. https://www.apjtm.org/text.asp?2023/16/3/129/372290
45. Mohan ME, Thomas JV, Mohan MC, et al. (2023) A proprietary black cumin oil extract (Nigella sativa) (BlaQmax(r)) modulates stress-sleep-immunity axis safely: Randomized double-blind placebo-controlled study. Front Nutr. 10:1152680. https://pubmed.ncbi.nlm.nih.gov/37139438
46. Alavinejad P, Aghadhani M, Bakhtiari N, et al. (2023) Evaluation of total black seed (Nigella sativa) extract efficacy in patients with irritable bowel syndrome – pilot study. Eur. Chem. Bull. 12:997-1006. https://www.eurchembull.com/uploads/paper/85fcfba8ff6ae017bd08ff7823739390.pdf
47. Alizadeh A, Mohammah-Alizadeh-Charandabi S, Khodaie L, Mirghafourvand M. (2023) Effect of Nigella sativa L. seed oil on urinary incontinence and quality of life in menopausal women: A triple-blind randomized controlled trial. Phytother Res. 37:2012-2023. https://pubmed.ncbi.nlm.nih.gov/36640148
48. Kolahdooz M, Nasri S, Modarres SZ, et al. (2014) Effects of Nigella sativa L. seed oil on abnormal semen quality in infertile men: a randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 21:901-905. https://pubmed.ncbi.nlm.nih.gov/24680621
49. Amalia A, Hendarto H, Mustika A, Susanti I (2022) Effects of Nigella Sativa on Female Infertility: A Systematic Review. Proc 6th Int Conf Med Health Inform. May 2022, 234-237. https://dl.acm.org/doi/abs/10.1145/3545729.3545776
50. Zakaria R, Astuti SCD (2022) The Effect of Black Cumin (Nigella Sativa) on Breastfeeding Mothers. J Info Kesehatan 20:29-40. https://jurnal.poltekeskupang.ac.id/index.php/infokes/article/view/627/437
51. Nemati S, Masroorchehr M, Elahi H, et al. (2021) Effects of Nigella sativa Extract on Chronic Rhinosinusitis: A Randomized Double Blind Study. Indian J Otolaryngol Head Neck Surg. 73:455-460. https://pubmed.ncbi.nlm.nih.gov/34722227
52. Bashar T, Misbahuddin M, Hossain MA. (2014) A double-blind, randomize, placebo-control trial to evaluate the effect of Nigella sativa on palmar arsenical keratosis patients. Bangladesh J Pharmacol. 9:15-21. http://www.bdpsjournal.org/index.php/bjp/article/view/188/611
53. Salem A, Bamosa A, Alam M, et al. (2021) Effect of Nigella sativa on general health and immune system in young healthy volunteers; a randomized, placebo-controlled, double-blinded clinical trial. F1000Research 10:1199 https://f1000research.com/articles/10-1199
54. Behnamfar N, Parsa Yekta Z, Mojab F, Kazem Naeini SM. (2019) The effect of nigella sativa oil on the prevention of phlebitis induced by chemotherapy: a clinical trial. Biomedicine (Taipei). 9:20. https://pubmed.ncbi.nlm.nih.gov/31453801
55. Hussain SA, Mohammed Ameen HA, Mohammed MO, et al. (2019) Nigella sativa Oil Mouth Rinse Improves Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia. Biomed Res Int. 2019:3619357. https://pubmed.ncbi.nlm.nih.gov/31781612
56. Rafati M, Ghasemi A, Saeedi M, et al. (2019) Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med. 47:102205. https://pubmed.ncbi.nlm.nih.gov/31780017
57. Mousa HFM, Abd-El-Fatah NK, Darwish OA, et al. (2017) Effect of Nigella sativa seed administration on prevention of febrile neutropenia during chemotherapy among children with brain tumors. Childs Nerv Syst. 33:793-800. https://pubmed.ncbi.nlm.nih.gov/28349493
58. Barakat EM, El Wakeel LM, Hagag RS. (2013) Effects of Nigella sativa on outcome of hepatitis C in Egypt. World J Gastroenterol. 19:2529-2536. https://pubmed.ncbi.nlm.nih.gov/23674855
59. Ahmed S, Zahoor A, Ibrahim M, et al. (2020) Enhanced Efficacy of Direct-Acting Antivirals in Hepatitis C Patients by Coadministration of Black Cumin and Ascorbate as Antioxidant Adjuvants. Oxid Med Cell Longev. 2020:7087921. https://pubmed.ncbi.nlm.nih.gov/32566096
60. Adiban Fard F, Tork Zahrani S, Akbarzadeh Bagheban A, Mojab F. (2015) Therapeutic Effects of Nigella Sativa Linn (Black Cumin) on Candida albicans Vaginitis. Arch Clin Infect Dis. 10:e22991. https://brieflands.com/articles/archcid-20960.pdf
61. Hashem-Dabaghian F, Agah S, Taghavi-Shirazi M, Ghobadi A. (2016) Combination of Nigella sativa and Honey in Eradication of Gastric Helicobacter pylori Infection. Iran Red Crescent Med J. 18:e23771. https://pubmed.ncbi.nlm.nih.gov/28191328
62. Alizadeh-Naini M, Yousefnejad H, Hejazi N. (2020) The beneficial health effects of Nigella sativa on Helicobacter pylori eradication, dyspepsia symptoms, and quality of life in infected patients: A pilot study. Phytother Res. 34:1367-1376. https://pubmed.ncbi.nlm.nih.gov/31916648
63. Mohtashami R, Huseini HF, Heydari M, et al. (2015) Efficacy and safety of honey based formulation of Nigella sativa seed oil in functional dyspepsia: A double blind randomized controlled clinical trial. J Ethnopharmacol. 175:147-52. https://pubmed.ncbi.nlm.nih.gov/26386381
64. Babu B, Rao P, Suman E, Udayalaxmi J (2023) A Study of Antibacterial Effect of Nigella Sativa Seed Extracts on Bacterial Isolates from Cases of Wound Infection. Infect Disord Drug Targets. 2023 Apr 3. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/37016531
65. Rafati S, Niakan M, Naseri M. (2014) Anti-microbial effect of Nigella sativa seed extract against staphylococcal skin Infection. Med J Islam Repub Iran. 28:42. https://pubmed.ncbi.nlm.nih.gov/25405108
66. Hannan A, Saleem S, Chaudhary S, et al. (2008) Anti bacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus. J Ayub Med Coll Abbottabad. 20:72-74. https://pubmed.ncbi.nlm.nih.gov/19610522
67. Liaqat F, Sheikh AA, Nazir J, et al. (2015) Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus. Pak J Pharm Sci. 28:997-1004. https://pubmed.ncbi.nlm.nih.gov/26004734
68. Elango A, Rao LN, Sugumar P, Radhakrishnan A. (2022) Evaluation of Clinical Efficacy and Safety of Nigella Sativa Seed Oil added to Standard Treatment in Uncomplicated Respiratory Infection – A Randomised, Open Labelled, and Parallel Arm Study. Special Issue – COVID-19 & Other Communicable Diseases 91-97. https://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/815/702
69. Yakoot M, Salem A. (2011) Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold. Int J Gen Med. 4:45-51. https://pubmed.ncbi.nlm.nih.gov/21403792
70. Abdallah HM, El-Halawany AM, Darwish KM, et al. (2022) Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics. Plants (Basel) 11:1914. https://pubmed.ncbi.nlm.nih.gov/35893619
71. Al-Haidari KAA, Faiq TAN, Ghareeb OA (2021) Preventive value of black seed in people at risk of infection with COVID-19. Pak J Med Health Sci. 15:384-387. https://pjmhsonline.com/2021/jan/384.pdf
72. Ashraf S, Ashraf S, Ashraf M, et al. (2023) DOCTORS LOUNGE consortium.(2023) Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial. Phytother Res. 37:627-644. https://pubmed.ncbi.nlm.nih.gov/36420866
73. Ashraf S, Ashraf S, Ashraf M, et al. (2020) Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial. medRxiv preprint, Nov 2020. https://www.medrxiv.org/content/10.1101/2020.10.30.20217364v4.full.pdf
74. Leal-Martínez F, Abarca-Bernal L, García-Pérez A, et al. (2022) Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health. 19:1172. https://pubmed.ncbi.nlm.nih.gov/35162195
75. Langen M (2023) Millions of avoidable deaths from COVID-19. Orthomolecular Medicine News Service. http://orthomolecular.org/resources/omns/v19n16.shtml
76. Al-Haidari KAA, Faiq TN, Ghareeb OA (2021) Clinical trial of black seeds against covid – 19 in Kirkuk city/Iraq. Indian J Foren Med Toxicol 15:3393-3399. https://www.revistaamplamente.com/index.php/ijfmt/article/view/15825
77. Koshak AE, Koshak EA, Mobeireek AF, et al. (2021) Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement Ther Med. 61:102769. https://pubmed.ncbi.nlm.nih.gov/34407441
78. Said SA, Abdulbaset A, El-Kholy AA, et al. (2022) The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial. Front Pharmacol. 13:1011522. https://pubmed.ncbi.nlm.nih.gov/36425571
79. Fraiman J, Erviti J, Jones M, et al. (2022) Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 40:5798-5805. https://pubmed.ncbi.nlm.nih.gov/36055877
80. Aarstad, J.; Kvitastein, O.A. Is there a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?. Asian Pac J Health Sci. 10:25-30. https://hvlopen.brage.unit.no/hvlopen-xmlui/bitstream/handle/11250/3062560/Aarstad.pdf
81. Rancourt DG, Baudin M, Hickey J, Mercier J (2023) Age-stratified COVID-19 vaccine-dose fatality rate for Israel and Australia. Correlation Research in the Public Interest. https://correlation-canada.org/report-age-stratified-covid-19-vaccine-dose-fatality-rate-for-israel-and-australia
82. Gøtzsche PC. (2014) Our prescription drugs kill us in large numbers. Pol Arch Med Wewn. 124:628-634. https://pubmed.ncbi.nlm.nih.gov/25355584
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)
Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)
Comments and media contact: drsaul@doctoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Riordan Clinic | Orthomolecular.org
3100 N Hillside Ave
Wichita, Kansas 67219
United States
Vitamin D Can Prevent and Treat Diabetes
Reproduced from original OMNS article (OrthoMolecular News Service):
http://orthomolecular.org/
Subscribe to the free Orthomolecular Newsletter: http://orthomolecular.org/subscribe.html
Go to the OMNS Archive: http://orthomolecular.org/resources/omns/index.shtml
Orthomolecular Medicine News Service, May 2, 2023
by Max Langen
OMNS (May 2, 2023) More than 460 million people, almost 6% of the world’s population, are suffering from type 2 diabetes, the most common form. Over 1 million deaths per year can be attributed to this condition, which makes it a leading cause of death. And the number of new cases is constantly increasing worldwide. By 2030, more than 7% will be suffering from type 2 diabetes. [1]
Besides the high number of fatalities caused by diabetes in “normal”, non-pandemic years, it is also one of the most important risk factors for severe or fatal courses of Covid-19. A new meta-analysis shows that diabetes is responsible for 17% of deaths from Covid-19. Diabetes is a strong risk factor for fatal courses of infectious diseases. To date, there are more than 7.5 million official Covid-deaths. Based on the results of the new meta-analysis, approx. 1.3 million of these deaths could have been avoided if no one in the world suffered from diabetes. [2]
Diabetes has various causes and risk factors, including an unhealthy pro-inflammatory diet, lack of physical activity, overweight/obesity, several micronutrient deficiencies, and mitochondrial dysfunction. [3] Diabetes can be greatly reduced and even reversed using a low-carbohydrate diet, a ketogenic diet, or intermittent fasting. [4-6] However, this article will focus on the role of vitamin D.
Type 2 diabetes
Recent evidence shows that a sufficient supply of vitamin D can protect from the most common forms of diabetes: type 2, type 1 and gestational diabetes. Meta-analyses of observational studies have shown that a low vitamin D level is an independent risk factor for the development of type 2 diabetes. [7] Individuals with a vitamin D level >25 ng/ml had a 43% lower risk of developing type 2 diabetes than those with a severely deficient level below 14 ng/ml. [8] Similarly, another study with people who had normal glucose levels or prediabetes showed that those with a level above 28 ng/ml had a 42% lower odds of developing or progressing to type 2 diabetes compared to those with a level below 18 ng/ml. [9]
However, the optimal range is well above 30 ng/ml. In a trial with women who were suffering from insulin resistance (which is the preliminary stage of type 2 diabetes) and had a deficiency of vitamin D, daily supplementation of 4000 IU for several months improved insulin resistance and insulin sensitivity more than a placebo. Importantly, insulin resistance was most strongly improved at or above 32 ng/ml. They found that the optimal level for the reduction of insulin resistance and thus for the prevention of type 2 diabetes was between 32 and 48 ng/ml. [10] In line with this finding, a study conducted by the health organization Grassrootshealth showed that a level of 41 ng/ml is associated with a 60% lower risk of developing type 2 diabetes compared with a level of 22 ng/ml. [11]
Several recent meta-analyses of RCTs (randomized controlled trials) showed that the association between a higher vitamin D level and a lower risk of type 2 diabetes is causal and dose-dependent. In patients with prediabetes, supplementation of vitamin D significantly reduced the risk of progressing to type 2 diabetes. [12,13] Supplementation to a higher vitamin D level (≥ 50 ng/ml vs. ≤ 30 ng/ml) reduced the risk for diabetes by a larger amount (76%). [14] The higher the level achieved, the more beneficial effect, up to ~60 ng/ml. This effect was more strongly pronounced in non-obese patients.
Since people with more weight or body fat need more vitamin D to reach a healthy level, it is likely that obese people did not receive the amount of vitamin D they required and therefore did not experience the same strong risk reduction as the non-obese people. Patients with prediabetes who received vitamin D also had a ~50% greater chance of reversing to a normal pre-diabetic state. The optimal vitamin D dose depends on many factors including the body weight and magnesium status. Vitamin D levels higher than 150 ng/ml can contribute to toxicity but are rare.
Direct mid-day summer sunlight on the skin can make adequate vitamin D with enough skin exposure. However sunlight does not cause vitamin D toxicity because at high vitamin D levels the body stops making it. Exposure to sunlight when the sun is less than 45 degrees above the horizon, or to sunlight through a glass window, though it can cause tanning, does not produce vitamin D (UVB light is required). Most of us don’t get enough vitamin D from our limited exposure to sunlight, especially in the winter. And although dermatologists warn that sun exposure can cause skin cancer, recent evidence suggests that moderate sun exposure (that produces vitamin D) may be protective against cancer.
Since 75% of the global adult population has an insufficient vitamin D level ( < 30 ng/ml ), [15] most are at increased risk of developing diabetes. Therefore it is not surprising that diabetes is on the rise worldwide. The vitamin D insufficiency situation is severely disease-promoting.
On the other hand, if all people had a very sunny level of vitamin D (40-60 ng/ml) probably most cases of type 2 diabetes could be prevented, which would also help to prevent many of the yearly 1 million deaths from diabetes. Further, as described above, more than a million deaths from Covid-19 are attributable to diabetes. Thus, a widespread correction of the worldwide vitamin D deficiency would have resulted in fewer deaths from infectious diseases like Covid-19.
Many doctors and researchers tried years ago to inform the public and governments about the “vitamin D deficiency pandemic”. [16-18] Unfortunately, there was hardly any interest in solving this tragedy. The reason is clearly described in an article by William Grant. [19] If your doctor tells you that a vitamin D level between 20 and 30 ng/ml is a “sufficient level”, refer to that article and explain that such levels are severely insufficient and strongly increase the risk of developing disease conditions such as infections and diabetes.
Besides lowering the risk of developing type 2 diabetes, vitamin D also helps to reverse the disease. In patients with type 2 diabetes and low vitamin D levels, supplementation with vitamin D significantly lowered blood glucose levels (fasting glucose level and long-term blood glucose value HbA1c) and improved insulin resistance. [20]
Type 2 diabetes is reversible with anti-diabetes drugs along with a protocol consisting of a temporal, slight caloric restriction, change to a healthy plant based diet, exercise and weight loss. After 12 months on such a protocol, approx. 50% of patients with type 2 diabetes achieved remission to a non-diabetic state and no longer required antidiabetic drugs. [21] Had the diabetic patients received ideal amounts of vitamin D as an addition to this program, the remission rate after 1 year would likely have been much higher.
Vitamin D also helps prevent and treat several of the complications that may arise from diabetes. For example, diabetics have twice the risk of developing depression compared with non-diabetics [22], and recent RCTs have shown that vitamin D effectively reduces depressive symptoms and may help prevent the development of major depressive disorder in patients with type 2 diabetes. [23,24] Diabetics also have increased cancer risks [25] and vitamin D has anti-cancer effects, with meta-analyses of RCTs showing that supplementation of vitamin D significantly reduces cancer mortality. [26]
About half of diabetics develop peripheral neuropathy, which is a form of nerve damage (due to increased glucose and decreased circulation) that affects limbs like legs, feet and arms and causes very uncomfortable and painful symptoms. [27] A deficiency of vitamin D seems to increase the risk of peripheral neuropathy. Supplementation with vitamin D in patients with diabetic peripheral neuropathy resulted in significantly reduced pain scores (up to 50% lower pain score after several months of continuous intake). [28]
Diabetic foot ulcers (a combination of neuropathy and ischemia) are one of the most devastating consequences of diabetes. Every year, millions of diabetics develop foot ulcers and up to 33% of all diabetics worldwide will suffer from a foot ulcer during their lifetime. Such ulcers often require amputation of lower limbs. Also, diabetics who develop foot ulcers have a 5-year mortality rate 2.5 times higher than those who did not develop such ulcers. [29]
A low vitamin D level is associated with a strongly increased risk of developing diabetic foot ulcers, suggesting that a sufficient level would reduce the incidence of this complication. [30] Also, vitamin D supplementation significantly hastened the healing process of diabetic foot ulcers. [31] Recent studies have confirmed that along with vitamin D, a sufficient supply of both magnesium and zinc is equally important to cure such ulcers. [32,33]
Cofactors of vitamin D also have an important role in the prevention of type 2 diabetes. Deficiencies of magnesium and vitamin K2 are very common among the public with almost half of the US population having an inadequate intake of magnesium [34] and up to 97% of older people suffering from an insufficiency of vitamin K2. [35] Type 2 diabetes is associated with low magnesium levels, [36] and a high dietary intake of magnesium was associated with a lower risk of developing type 2 diabetes. [37] Also, magnesium supplementation helps treat prediabetes and type 2 diabetes, and significantly reduced glucose parameters and improved insulin sensitivity in such patients. [37] Type 2 diabetics have significantly lower vitamin K2 levels than healthy controls, [38] and supplementation of K2 significantly reduced glucose levels (fasting glucose and HbA1c) in patients with diabetes. [39]
The incidence of type 2 diabetes would likely be drastically reduced if all people could get adequate amounts vitamin D and its most important cofactors like magnesium and vitamin K2.
Type 1 diabetes
Type 1 diabetes is an autoimmune disease, and recent evidence from the VITAL study shows that long term supplementation with vitamin D significantly reduces the risk of developing autoimmune diseases. [40,41] Regarding the specific diagnosis of type 1 diabetes, a sufficient level of vitamin D compared to the lowest levels reduces the risk of type 1 diabetes by approximately 60%. A level of ~45 ng/ml was associated with the lowest risk (72% lower) of type 1 diabetes. [42] A sunny level above 40 ng/ml seems to optimize protection against autoimmune conditions. Note again that world-wide, most adults have an insufficient level below 30 ng/ml — and it appears that most are unaware of this important information.
Other meta-analyses showed that supplementation of vitamin D during infancy is associated with ~30% lower risk of developing type 1 diabetes later in life, [43,44] suggesting that vitamin D helps the immune system to develop better.
The risk of developing type 1 diabetes can be reduced with a sufficient level of vitamin D. But even if the disease is already established, vitamin D should be considered as a treatment. RCTs show that vitamin D supplementation may attenuate the “natural history of the disease”, by improving fasting and stimulated C-peptide levels, allowing a lower required insulin dose. This indicates that the performance of the pancreas has improved due to vitamin D. [45]
Importantly, since type 1 diabetes is an autoimmune disease, it may be strongly improved or (depending on the stage) even brought into remission by the coimbra-protocol. The coimbra-protocol has shown to be a remarkably effective treatment for many forms of autoimmune conditions. Its central component is very high dose vitamin D. People who are interested in the coimbra-protocol should work together with a therapist or doctor who is trained in the protocol. Search for coimbra-doctors. The daily doses are much higher than what is typically recommended by vitamin D researchers and may lead to negative effects if they are not constantly adjusted based on several lab parameters. In order to make the treatment work and to prevent harm from high levels of vitamin D, the dose needs to be adjusted based on individual needs and testing results, the diet needs to be adapted (low calcium, etc.), and frequent blood examinations are required to make sure that no safety issues occur. However, contrary to some of the typical negative anti-vitamin D articles in the mainstream press, the experience of many coimbra-therapists around the world with thousands of strongly improved patients and published data of many individuals shows that the coimbra protocol is reliably safe if the patients are adequately supervised by trained coimbra-therapists/ physicians. [46] Those who use this protocol for the treatment of an autoimmune disease are likely to experience strong clinical improvements or even remission.
Gestational diabetes mellitus
In line with other forms of diabetes, the incidence of gestational diabetes mellitus (GDM) is increasing and affects millions of pregnant women worldwide. In the USA, up to 10% of pregnant women develop the condition. [47] It is one of the most common complications during pregnancy, and increases the risk of adverse pregnancy and neonatal outcomes like preterm delivery, cesarean delivery, or respiratory distress syndrome in the infant or requiring admission to the neonatal ICU. [48] Also, women who develop gestational diabetes (GDM) have a high risk of developing type 2 diabetes in the following years.
A deficiency of vitamin D seems to be an important cause. Women with a low level of 25(OH)D had a significantly higher risk of GDM than those with a sufficient level. [49] A meta-analysis of RCTs proved that supplementation of vitamin D during pregnancy improves blood glucose levels and reduces the risk of developing gestational diabetes by 58%. [50] Of note, a daily dose of > 2000 IU is required for the prevention of diabetes during pregnancy. [51] Many cases of GDM may be preventable with a sufficient supply of vitamin D.
In addition, vitamin D supplementation in pregnant women with GDM can massively reduce the risk of adverse neonatal outcomes. In fact, in women with GDM, supplementation of vitamin D decreased the risk of premature delivery by 63%. Similarly, the risk of the neonates requiring hospitalization after birth was reduced by 62% due to vitamin D supplementation during pregnancy. [52] This means vitamin D not only prevents GDM, but in women who have developed the condition it can also protect the unborn from harm caused by the disease and decrease the risk of negative fetal and neonatal health outcomes.
And importantly – independent from gestational diabetes- supplementation of sufficient amounts of vitamin D during pregnancy can also save many lives. A new meta-analysis of RCTs has shown that vitamin D supplementation in adequate doses during pregnancy reduced the risk of intrauterine or neonatal death by more than 30%, [53] which may allow thousands of unborn or neonates to survive if pregnant women achieved and maintained sufficient tissue levels of vitamin D.
Conclusion
The level of vitamin D and its cofactors magnesium and vitamin K2 are widely deficient in individuals throughout the world. These deficiencies attenuate the function of the body’s immune system and contribute to widespread disease and death that could be prevented with adequate supplements. In many cases, type 2 diabetes can be prevented and reversed with a protocol of essential nutrients that includes vitamin D, magnesium, vitamin K2, and mild dietary restriction in a low-sugar diet with colorful raw and cooked vegetables. Many people including medical professionals are unaware of the problem and its solution. Please spread the word!
References:
1. Khan MAB, Hashim MJ, King JK, et al. (2020) Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 10:107-111. https://pubmed.ncbi.nlm.nih.gov/32175717
2. Li R, Shen M, Yang Q, et al. (2023) Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 46:890-897. https://pubmed.ncbi.nlm.nih.gov/36826982
3. Rovira-Llopis S, Bañuls C, Diaz-Morales N, et al. (2017) Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications. Redox Biol. 11:637-645. https://pubmed.ncbi.nlm.nih.gov/28131082
4. Volek JS, Phinney SD, Krauss RM, et al. (2021) Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets. Nutrients. 13:3299. https://pubmed.ncbi.nlm.nih.gov/34684300
5. Khalfallah M, Elnagar B, Soliman SS, et al. (2023) The Value of Intermittent Fasting and Low Carbohydrate Diet in Prediabetic Patients for the Prevention of Cardiovascular Diseases. Arq Bras Cardiol. 120(4):e20220606. https://pubmed.ncbi.nlm.nih.gov/37042857
6. Sethi S, Ford JM. (2022) The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review. J Psychiatr Brain Sci. 7(5):e220009. https://pubmed.ncbi.nlm.nih.gov/36483840
7. Lucato P, Solmi M, Maggi S, et al. (2017) Low vitamin D levels increase the risk of type 2 diabetes in older adults: A systematic review and meta-analysis. Maturitas 100:8-15. https://pubmed.ncbi.nlm.nih.gov/28539181
8. Mitri J, Muraru MD, Pittas AG. (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 65:1005-1015. https://pubmed.ncbi.nlm.nih.gov/21731035
9. Deleskog, A., Hilding, A., Brismar, K. et al. (2012) Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 55:1668-1678. https://pubmed.ncbi.nlm.nih.gov/22426800
10. von Hurst PR, Stonehouse W, Coad J. (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr. 103:549-555. https://pubmed.ncbi.nlm.nih.gov/19781131
11. McDonnell SL, Baggerly LL, French CB, et al. (2016) Incidence rate of type 2 diabetes is >50% lower in GrassrootsHealth cohort with median serum 25-hydroxyvitamin D of 41 ng/ml than in NHANES cohort with median of 22 ng/ml. J Steroid Biochem Mol Biol. 155(Pt B):239-244. https://pubmed.ncbi.nlm.nih.gov/26151742
12. Zhang Y, Tan H, Tang J, et al. (2020) Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care 43:1650-1658. https://pubmed.ncbi.nlm.nih.gov/33534730
13. Barbarawi M, Zayed Y, Barbarawi O, et al. (2020) Effect of Vitamin D Supplementation on the Incidence of Diabetes Mellitus. J Clin Endocrinol Metab. 105:dgaa335. https://pubmed.ncbi.nlm.nih.gov/32491181
14. Pittas AG, Kawahara T, Jorde R, et al. (2023) Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 176:355-363. https://pubmed.ncbi.nlm.nih.gov/36745886
15. Reddy P, Edwards LR. (2019) Magnesium Supplementation in Vitamin D Deficiency. Am J Ther. 26:e124-e132. https://pubmed.ncbi.nlm.nih.gov/28471760
16. grassrootshealth.net (2015) Scientists’ Call to D*action – The Vitamin D Deficiency Epidemic. https://www.grassrootshealth.net/project/our-scientists
https://www.grassrootshealth.net/wp-content/uploads/2017/12/scientists_call-to-daction_121817.pdf
17. Holick MF, Chen TC. (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 87:1080S-1086S. https://pubmed.ncbi.nlm.nih.gov/18400738
18. Holick MF. (2017) The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 18:153-165. https://pubmed.ncbi.nlm.nih.gov/28516265
19. Grant WB (2018) Vitamin D acceptance delayed by Big Pharma following the Disinformation Playbook. Orthomolecular Medicine News Service. http://orthomolecular.org/resources/omns/v14n22.shtml
20. Farahmand MA, Daneshzad E, Fung TT, et al. (2023) What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trails. BMC Endocr Disord. 23:15. https://pubmed.ncbi.nlm.nih.gov/36647067
21. Lean ME, Leslie WS, Barnes AC, et al. (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 391:541-551. https://pubmed.ncbi.nlm.nih.gov/29221645
22. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 24:1069-1078. https://pubmed.ncbi.nlm.nih.gov/11375373
23. Putranto R, Harimurti K, Setiati S, et al. (2022) The Effect of Vitamin D Supplementation on Symptoms of Depression in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Acta Med Indones. 54:574-584. https://pubmed.ncbi.nlm.nih.gov/36624711
24. Omidian M, Mahmoudi M, Abshirini M, et al. (2019) Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial. Diabetes Metab Syndr. 13:2375-2380. https://pubmed.ncbi.nlm.nih.gov/31405646
25. Wojciechowska J, Krajewski W, Bolanowski M, et al. (2016) Diabetes and Cancer: a Review of Current Knowledge. Exp Clin Endocrinol Diabetes 124:263-275. https://pubmed.ncbi.nlm.nih.gov/27219686
26. Keum N, Lee DH, Greenwood DC, et al. (2019) Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 30:733-743. https://pubmed.ncbi.nlm.nih.gov/30796437
27. NIDDK, Peripheral Neuropathy. https://niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathies/peripheral-neuropathy
28. Putz Z, Tordai D, Hajdú N, et al. (2022) Vitamin D in the Prevention and Treatment of Diabetic Neuropathy. Clin Ther. 44:813-823. https://pubmed.ncbi.nlm.nih.gov/35428527
29. Edmonds M, Manu C, Vas P. (2021) The current burden of diabetic foot disease. J Clin Orthop Trauma. 17:88-93. https://pubmed.ncbi.nlm.nih.gov/33680841
30. Dai J, Jiang C, Chen H, Chai Y. (2019) Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis. Nutr Diabetes. 9:8. https://pubmed.ncbi.nlm.nih.gov/30858355
31. Kinesya E, Santoso D, Gde Arya N, et al. (2023) Vitamin D as adjuvant therapy for diabetic foot ulcers: Systematic review and meta-analysis approach. Clin Nutr ESPEN. 54:137-143. https://pubmed.ncbi.nlm.nih.gov/36963855
32. Razzaghi R, Pidar F, Momen-Heravi M, et al. (2018) Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 181:207-215. https://pubmed.ncbi.nlm.nih.gov/28540570
33. Momen-Heravi M, Barahimi E, Razzaghi R, et al. (2017) The effects of zinc supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Wound Repair Regen. 25:512-520. https://pubmed.ncbi.nlm.nih.gov/28395131
34. Gröber U, Schmidt J, Kisters K. (2015) Magnesium in Prevention and Therapy. Nutrients. 7:8199-8226. https://pubmed.ncbi.nlm.nih.gov/26404370
35. Langen, M (2023) Nutritional Risk Factors in Suicide: How Vitamin D Can Help. Orthomolecular Medicine News Service. http://orthomolecular.org/resources/omns/v19n18.shtml
36. Fang X, Han H, Li M, et al. (2016) Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients. 8:739. https://pubmed.ncbi.nlm.nih.gov/27869762
37. Veronese N, Dominguez LJ, Pizzol D, et al. (2021) Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 13:4074. https://pubmed.ncbi.nlm.nih.gov/34836329
38. Helmy MY, Elsaid NH, Gwad MMA. (2022) The Association of Vitamin K2 Level with the Glycaemic Status in Type 2 Diabetic Patients: A Case-Control Study. Indian J Endocrinol Metab. 26:87-92. https://pubmed.ncbi.nlm.nih.gov/35662764
39. Rahimi Sakak F, Moslehi N, Niroomand M, Mirmiran P. (2021) Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial. Eur J Nutr. 60:2495-2506. https://pubmed.ncbi.nlm.nih.gov/33159574
40. Hahn J, Cook NR, Alexander EK, et al. (2022) Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 376:e066452. https://pubmed.ncbi.nlm.nih.gov/35082139
41. McCullough PJ, McCullough WP, Lehrer D, et al (2021) Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications. Nutrients 13:1511. https://pubmed.ncbi.nlm.nih.gov/33947070
42. Hou Y, Song A, Jin Y, et al. (2021) A dose-response meta-analysis between serum concentration of 25-hydroxy vitamin D and risk of type 1 diabetes mellitus. Eur J Clin Nutr. 75:1010-1023. https://pubmed.ncbi.nlm.nih.gov/33235321
43. Zipitis CS, Akobeng AK. (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 93:512-517. https://pubmed.ncbi.nlm.nih.gov/18339654
44. Dong JY, Zhang WG, Chen JJ, et al. (2013) Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients. 5:3551-3562. https://pubmed.ncbi.nlm.nih.gov/24036529
45. Gregoriou E, Mamais I, Tzanetakou I, Lavranos G, et al. (2017) The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. Rev Diabet Stud. 14:260-268. https://pubmed.ncbi.nlm.nih.gov/29145536
46. Amon U, Yaguboglu R, Ennis M, Holick MF, Amon J. (2022) Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the “Coimbra Protocol”. Nutrients. 14:1575. https://pubmed.ncbi.nlm.nih.gov/35458137
47. Lende M, Rijhsinghani A. (2020) Gestational Diabetes: Overview with Emphasis on Medical Management. Int J Environ Res Public Health. 17:9573. https://pubmed.ncbi.nlm.nih.gov/33371325
48. Ye W, Luo C, Huang J, et al. (2022) Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 377:e067946. https://pubmed.ncbi.nlm.nih.gov/35613728
49. Zhao R, Zhou L, Wang S, Xiong G, Hao L. (2022) Association between maternal vitamin D levels and risk of adverse pregnancy outcomes: a systematic review and dose-response meta-analysis. Food Funct. 13:14-37. https://pubmed.ncbi.nlm.nih.gov/34859252
50. Yin W, Jin D, Yao M, Yu W, Zhu P. (2019) [Effect of vitamin D supplementation on gestational diabetes mellitus:a Meta-analysis]. Wei Sheng Yan Jiu. 48:811-821. Chinese. https://pubmed.ncbi.nlm.nih.gov/31601326
51. Irwinda R, Hiksas R, Lokeswara AW, Wibowo N. (2022) Vitamin D supplementation higher than 2000 IU/day compared to lower dose on maternal-fetal outcome: Systematic review and meta-analysis. Womens Health (Lond). 18:17455057221111066. https://pubmed.ncbi.nlm.nih.gov/35796578
52. Wu C, Song Y, Wang X. (2023) Vitamin D Supplementation for the Outcomes of Patients with Gestational Diabetes Mellitus and Neonates: A Meta-Analysis and Systematic Review. Int J Clin Pract. 2023:1907222. https://pubmed.ncbi.nlm.nih.gov/36713951
53. Liu Y, Ding C, Xu R, et al. (2022) Effects of vitamin D supplementation during pregnancy on offspring health at birth: A meta-analysis of randomized controlled trails. Clin Nutr. 41:1532-1540. https://pubmed.ncbi.nlm.nih.gov/35667269
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)
Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)
Comments and media contact: drsaul@doctoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Riordan Clinic | Orthomolecular.org
3100 N Hillside Ave
Wichita, Kansas 67219
United States
Eliminate ulcerative colitis naturally
Reproduced from original article:
www.naturalhealth365.com/ulcerative-colitis-ibd-3654.html
by: Karen Sanders, staff writer | December 10, 2020
(NaturalHealth365) With inflammatory bowel disease on the rise in the United States, the tab for treating this condition is rising as well. In fact, according to the U.S. Centers for Disease Control and Prevention (CDC), ‘those with IBD are more likely to have certain chronic health conditions that include: cardiovascular disease, respiratory disease and cancer.’
These conditions – which are obviously life-threatening – have no known (conventional) medical cure, and doctors aren’t even sure what causes them, although integrative healthcare providers believe our increasingly toxic environment does play a role. Just consider how serious this is: 3 out of 4 Crohn’s disease sufferers will eventually need surgery; and for ulcerative colitis, the estimate is 1 out of 4.
When will Western medicine wake up? Toxic drugs will NEVER solve the underlying cause of ulcerative colitis
Conventionally-trained doctors tend to treat symptoms with drugs such as aminosalicylates and steroids, but these medications can cause a host of serious side effects, including high blood pressure, osteoporosis, diabetes, glaucoma, inability to absorb certain nutrients, and increased risk of infection.
Given these bleak facts, wouldn’t it be wonderful if there were a safe, natural way of reducing the inflammation that lies at the heart of these conditions?
Herbal medicine can help to eliminate digestive disorders
Boswellia serrata, also called “Indian frankincense” and Salai guggul, has been prized in Ayurvedic medicine for thousands of years as a remedy for digestive disorders, respiratory problems and inflammatory diseases. Over the last few decades, conventional medical authorities and institutions have begun to acknowledge what boswellia can do.
Boswellia resin, which is obtained from plant’s thick, flexible bark, contains triterpenes known as boswellic acids; scientists think these are the key to the plant’s anti-inflammatory effects. Boswellia resin also contains essential oils which are rich in alpha-thujene – a pungent monoterpene – and p-cymene, an aromatic compound also found in beneficial herbs such as thyme.
Do NOT ignore the health dangers linked to toxic indoor air. These chemicals – the ‘off-gassing’ of paints, mattresses, carpets and other home/office building materials – increase your risk of headaches, dementia, heart disease and cancer.
Get the BEST indoor air purification system – at the LOWEST price, exclusively for NaturalHealth365 readers. I, personally use this system in my home AND office. Click HERE to order now – before the sale ends.
The University of Maryland Medical Center (UMMC) reports boswellic acids inhibit a specific enzyme that is vital in the biosynthesis of leukotrienes – inflammatory molecules believed to contribute to ulcerative colitis and other inflammatory diseases.
Is boswellia better than conventional drugs?
Although boswellia is not commonly recommended by conventional doctors to treat IBD, its ability to treat ulcerative colitis and Crohn’s disease – and do it more effectively and safely than prescription drugs – has been supported by close to 20 years of research. UMMC cites a 1997 clinical study in which boswellia’s therapeutic effects were equal to those of sulfasalazine, a pharmaceutical IBD treatment.
The study, published in European Journal of Medical Research, explored the effects of boswellia on patients diagnosed with grade II and grade III ulcerative colitis. Subjects were given 350 milligrams of boswellia extracts three times a day for 6 weeks, after which researchers used microscopies of rectal biopsies and examined relevant blood parameters – including levels of leukocytes and esinophils – to determine the results.
They found that the boswellia group showed improvement in all parameters, with 82 percent going into remission, as compared to 75 percent for the sulfasalazine group. In other words, boswellia outperformed the pharmaceutical drug.
Four years later, a 2001 study published in Planta Medica showed an even wider divide between boswellia and sulfasalazine’s effects. Thirty patients with chronic colitis were given either 900 milligrams of boswellia or 3000 milligrams of sulfasalazine daily for six weeks.
Ninety percent of the boswellia patients showed improvement in symptoms, as compared to 60 percent of the sulfasalazine group. The study’s author concluded that boswellia could be used to effectively treat colitis with minimal side effects.
Finally, in a review published in 2001 in Gastroenterology, boswellia was found to be as exactly as effective as the pharmaceutical drug mesalamine in treating acute Crohn’s disease.
Don’t you wish these studies were required reading for all gastroenterologists?
Some conventionally-trained physicians support the use of boswellia
Another “plus” for boswellia is that fact that it doesn’t damage the digestive tract. According to Memorial Sloan-Kettering Cancer Center, boswellia – unlike current non-steroidal anti-inflammatory drugs – does not cause gastric ulcers, another testament to this remarkable herb’s safety and efficacy.
Boswellia attacks inflammation on many fronts.
In a German review, presented by the Institute of Pharmaceutical Sciences at University of Tuebingen and published in 2010 in Phytomedicine, the authors reviewed the method of action of boswellic acids. They noted the acids affect cellular defense while exhibiting action in the immune system.
Boswellic acids also down regulate inflammatory cytokines, cut production of leukotrienes and demonstrate antioxidant activity while inhibiting the formation of free radicals. Given these activities, the authors of the review called boswellia’s therapeutic effects on ulcerative colitis and Crohn’s disease “not surprising.” They called for further studies in order to explore optimal dosages.
How can I take boswellia?
Boswellia, usually standardized to contain between 37.5 and 65 percent boswellic acid, is available in resin, pill and cream form. UMMC notes that the standard boswellia amount for ulcerative colitis is 550 milligrams, 3 times a day for up to six weeks.
Of course, you should consult with a trusted doctor before using boswellia for any digestive issues; and your doctor can advise you as to the proper amount, and how long to continue taking boswellia.
Keep in mind, boswellia can stimulate blood flow in the uterus and could induce miscarriage – so, do not take it if you are pregnant. Side effects of boswellia can include digestive discomfort; as with any substance, an allergy to boswellia is possible.
Sources for this article include:
Study Links Tylenol Consumption with Risk Taking
© 15th September 2020 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here www.greenmedinfo.com/greenmed/newsletter
Reproduced from original article:
www.greenmedinfo.com/blog/study-links-tylenol-consumption-risk-taking
Posted on: Tuesday, September 15th 2020 at 9:15 am
Written By: GreenMedInfo Research Group
This article is copyrighted by GreenMedInfo LLC, 2020

The psychological side effects of acetaminophen, aka Tylenol, continue to mount, with research showing users are more likely to make risky decisions. When coupled with past research linking this supposedly safe pain reliever to blunted empathy and emotions, the widespread social effects on society could be immense
Acetaminophen, commonly known by its brand name Tylenol, is one of the most commonly used medications worldwide — and research suggests it could be causing users to engage in more risky behaviors.[1] In the U.S. alone, acetaminophen can be found in more than 600 prescription and over-the-counter drugs and is taken by 23% of — or 52 million — Americans each week.[2]
Many don’t think twice about popping a Tylenol or two to relieve a headache, reduce a fever or ease minor aches and pains or cold and allergy symptoms, but research continues to reveal that this supposedly “safe” pain reliever has more risks than many people realize. Among them are surprising effects on psychological processes such as behavior and perception, including altering willingness to take risks.
Considering that so many people take acetaminophen on a daily basis, even slight changes in risk-taking behaviors “could have important effects on society,” study co-author Baldwin Way, an associate professor of psychology at The Ohio State University, noted in a press release.[3]
Acetaminophen Makes People More Likely to Take Risks
The study involved 189 college students, who took a standard recommended adult dosage of 1,000 milligrams (mg) of acetaminophen or a placebo. They were then asked to rate the riskiness of activities such as bungee jumping, taking a skydiving class, walking home alone at night in an unsafe area and starting a new career in your mid-30s.
Those under the influence of acetaminophen rated these activities as less risky than those who took a placebo. “Acetaminophen seems to make people feel less negative emotion when they consider risky activities — they just don’t feel as scared,” Way said.[4]
In a second part of the study, 545 college students took part in a computer task intended to measure risk-taking behavior. The students had to click a button to inflate a balloon in order to earn money. The bigger the balloon, the more money they would receive, but if the balloon got too big and burst, they would lose their money.
As in the first study, those who took acetaminophen took more risk, pumping the balloons more times and earning more burst balloons, than those who took a placebo. “If you’re risk-averse, you may pump a few times and then decide to cash out because you don’t want the balloon to burst and lose your money,” Way said. “But for those who are on acetaminophen, as the balloon gets bigger, we believe they have less anxiety and less negative emotion about how big the balloon is getting and the possibility of it bursting.”[5]
It’s previously been suggested that those with increased risk-taking on these types of computer-simulated tasks may be more likely to engage in risky behaviors in real-life as well, including using drugs and alcohol, stealing and driving without a seatbelt.[6]
Acetaminophen Blunts Empathy, Positive and Negative Emotions
While potentially increasing risky behaviors, acetaminophen has also been found to blunt both positive and negative emotions. In this way, Way and colleagues revealed in 2015 that over-the-counter acetaminophen provides relief from “pain and pleasures alike,” essentially dampening users’ ability to experience emotionally pleasurable sensations.[7]
The next year, in 2016, Way and colleagues found acetaminophen to be an “empathy killer,”[8] as it reduced users’ empathy in response to others’ pain. Because empathy plays an important role in prosocial and antisocial behaviors, acetaminophen-induced alterations in empathy could be having broad social side effects.[9]
In a 2019 study, Way and colleagues again compared acetaminophen to a “social analgesic,” stating that it blunts “social pain” by reducing the activity of the anterior insula and anterior cingulate brain regions, which are associated with emotional awareness and motivation.[10] Even positive empathy was blunted by the drug.
When people were given 1,000 mg of acetaminophen, then read scenarios about uplifting experiences of other people, the acetaminophen reduced personal pleasure and empathic feelings directed toward others, once again suggesting that the widespread use of acetaminophen could be having a negative effect on prosocial behavior on a societal level.[11]
Acetaminophen has also been found to cause an “inhibition of evaluative processing,”[12] meaning it could alter your ability to make decisions and cause you to react slower or miss errors that you would spot otherwise.[13]
Acetaminophen Is ‘Not Particularly Effective’ or Safe
Acetaminophen’s reputation as a “safe and effective” painkiller is increasingly being called into question, and anyone who uses it should be aware that in addition to psychological effects, acetaminophen is linked to serious physical adverse effects.
GreenMedInfo.com has compiled 236 studies related to acetaminophen’s toxicity, and a European Journal of Hospital Pharmacy editorial concluded, “We have considerable evidence that as well as not being particularly effective, neither is it particularly safe.”[14] Some of the health risks linked to acetaminophen use include:[15]
- Increased mortality
- Cardiovascular adverse events, including heart attack, stroke and fatal coronary artery disease
- Gastrointestinal adverse events, including gastroduodenal ulcers and upper gastrointestinal hemorrhage
- Acute liver failure necessitating transplantation
- Abnormal liver function
What’s more, acetaminophen has been shown to be ineffective for treating back pain, “practically ineffective” for arthritis and “in the least effective quartile of drugs” for treating postoperative pain. It’s also only modestly effective for migraines and tension-type headaches, while no evidence shows that it works to relieve pain related to cancer, menstrual cramps, rheumatoid arthritis or the neck.[16]
Considering its significant risks — including psychological risks that are only beginning to be understood and explored–and questionable effectiveness, it makes sense to try nontoxic, natural pain relief options first — of which there are hundreds to choose from.
References
[1] Social Cognitive and Affective Neuroscience, nsaa108, https://doi.org/10.1093/scan/nsaa108, https://academic.oup.com/scan/advance-article/doi/10.1093/scan/nsaa108/5897711
[2] Consumer Healthcare Products Association, Acetaminophen https://www.chpa.org/Acetaminophen.aspx
[3] Ohio State News September 8, 2020 https://news.osu.edu/a-pain-reliever-that-alters-perceptions-of-risk/
[4] Ohio State News September 8, 2020 https://news.osu.edu/a-pain-reliever-that-alters-perceptions-of-risk/
[5] Ohio State News September 8, 2020 https://news.osu.edu/a-pain-reliever-that-alters-perceptions-of-risk/
[6] Ohio State News September 8, 2020 https://news.osu.edu/a-pain-reliever-that-alters-perceptions-of-risk/
[7] Psychological Science April 10, 2015 https://journals.sagepub.com/doi/abs/10.1177/0956797615570366
[8] Soc Cogn Affect Neurosci. 2016 Sep; 11(9): 1345-1353. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015806/
[9] Soc Cogn Affect Neurosci. 2016 Sep; 11(9): 1345-1353. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015806/
[10] Front Psychol. 2019; 10: 538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455058/
[11] Front Psychol. 2019; 10: 538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455058/
[12] Social Cognitive and Affective Neuroscience, Volume 11, Issue 6, June 2016, Pages 899-906, https://doi.org/10.1093/scan/nsw023, https://academic.oup.com/scan/article/11/6/899/2224073
[13] Science Alert April 12, 2016 https://www.sciencealert.com/tylenol-may-make-it-harder-for-users-to-spot-errors-says-study
[14] European Journal of Hospital Pharmacy Volume 23, Issue 4 https://ejhp.bmj.com/content/23/4/187
[15] European Journal of Hospital Pharmacy Volume 23, Issue 4 https://ejhp.bmj.com/content/23/4/187
[16] European Journal of Hospital Pharmacy Volume 23, Issue 4 https://ejhp.bmj.com/content/23/4/187
The GMI Research Group (GMIRG) is dedicated to investigating the most important health and environmental issues of the day. Special emphasis will be placed on environmental health. Our focused and deep research will explore the many ways in which the present condition of the human body directly reflects the true state of the ambient environment.
